Meanwhile the share price may well drift back to under 11p... Regarding the other clinical trials with AZN etc al these are slow burn could take months to see if they move to the next stage.

Angle (LON:AGL) is a small share that's skyrocketed in recent weeks. Why does this investor hold the high-risk penny stock?

Shares of ANGLE plc (LON:AGL – Get Free Report) traded down 9.4% on Saturday . The company traded as low as GBX 14.22 ($0.18) and last traded at GBX 14.50 ($0.18). 1,973,299 shares were traded during ...

Angle estimated a full-year loss of GBP14 million in 2024, down 30% from the previous year's GBP20.1 million loss. The firm expects to report revenue surging by 31% to GBP2.9 million from GBP2.2 ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

However, I won’t complain, and I’m optimistic the share price could head higher ... and monitor to see if the disease has returned. Angle’s pioneered the Parsortix liquid biopsy system.